Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Troponin I anticorps (AA 186-192)

L’anticorps Souris Monoclonal anti-Troponin I a été validé pour WB, ELISA, IHC et IP. Il convient pour détecter Troponin I dans des échantillons de Humain. Il y a 5+ publications disponibles.
N° du produit ABIN284801

Aperçu rapide pour Troponin I anticorps (AA 186-192) (ABIN284801)

Antigène

Voir toutes Troponin I (TNNI) Anticorps
Troponin I (TNNI)

Reactivité

  • 47
  • 19
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
Humain

Hôte

  • 35
  • 26
  • 2
Souris

Clonalité

  • 37
  • 26
Monoclonal

Conjugué

  • 29
  • 7
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Troponin I est non-conjugé

Application

  • 48
  • 35
  • 22
  • 13
  • 13
  • 11
  • 8
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)

Clone

C5
  • Épitope

    • 15
    • 15
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 186-192

    Purification

    purified

    Immunogène

    Troponin I antibody (cardiac) was raised in mouse using amino acid residues 186-192 of cTnI as the immunogen.

    Isotype

    IgG2b
  • Indications d'application

    Optimal conditions should be determined byt he investigator.

    Restrictions

    For Research Use only
  • Concentration

    Lot specific

    Buffer

    Protein A purified and supplied in PBS, pH 7.4, 0.1 % NaN3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C
  • Lin, Schmidt, Fritz, Jeong, Cammarato, Foster, Biesiadecki, McKinsey, Woulfe: "Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity." dans: Journal of molecular and cellular cardiology, Vol. 139, pp. 135-147, (2020) (PubMed).

    Waas, Weerasekera, Kropp, Romero-Tejeda, Poon, Boheler, Burridge, Gundry: "Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry." dans: Stem cell reports, Vol. 12, Issue 2, pp. 395-410, (2020) (PubMed).

    Woulfe, Ferrara, Pioner, Mahaffey, Coppini, Scellini, Ferrantini, Piroddi, Tesi, Poggesi, Jeong: "A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study." dans: Frontiers in cardiovascular medicine, Vol. 6, pp. 12, (2019) (PubMed).

    Lin, Warren, Li, McKinsey, Russell: "Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ." dans: Cellular signalling, Vol. 28, Issue 8, pp. 1015-24, (2017) (PubMed).

    Scruggs, Walker, Lyu, Geenen, Solaro, Buttrick, Goldspink: "Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation." dans: Journal of molecular and cellular cardiology, Vol. 40, Issue 4, pp. 465-73, (2006) (PubMed).

  • Antigène

    Troponin I (TNNI)

    Autre désignation

    Troponin I
Vous êtes ici:
Chat with us!